Genmab A/S

Genmab A/S is a leading biotechnology company that specializes in developing innovative antibody therapeutics for cancer treatment. Established in 1999, the company has a strong focus on research and development, with a pipeline of promising drug candidates in various stages of clinical development. Genmab's flagship product, Darzalex, is a first-in-class antibody therapy for multiple myeloma, approved in over 90 countries worldwide. The company's DuoBody technology platform enables the creation of bispecific antibodies that can target multiple disease targets simultaneously, offering a potential breakthrough in cancer treatment. With a global presence and a team of over 600 employees, Genmab is dedicated to improving the lives of cancer patients through the development of innovative and effective therapies.

Instrument specification for Genmab A/S

Minimum order value 1
Description Genmab A/S
Maximum order value 150
Transaction Step 1
Type Equities DK
Trading Hours monday-friday 09:01-16:54
Contract size / 1 lot Price * 1 DKK
Deposit required 20%
Value of 1 pip 0.01
Financial leverage 5:1
Minimal step 0.01
Long swap (daily) -0.01811%
Short sale YES
Short swap (daily) 0.00144%
Distance SL and TP 0
3-day swap (date) 5

Speedy account opening, start investing now.

Discover how to get ahead of the competition

Open account
Over 20 years in the markets, the best analysis, modern tools and thousands of satisfied customers. Trade with an award-winning broker
Get access to global markets - thousands of instruments at your fingertips. Make decisions based on current data - daily opportunities and recommendations.
Take control - mobile tools for investment management. Trade without unnecessary costs - no commission on major instruments. Transparent pricing and historical spreads
Scroll to top